Federated Hermes, Inc. Baxter International Inc Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 85,576 shares of BAX stock, worth $2.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

85,576

Previous 178,881 52.16%

Holding current value

$2.96 Million

Previous $7.65 Million 62.56%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$32.87 - $43.55 $3.07 Million - $4.06 Million	-93,305 Reduced 52.16%	85,576 $2.86 Million
Q1 2024 May 14, 2024	SELL	$37.88 - $43.77 $115,382 - $133,323	-3,046 Reduced 1.67%	178,881 $7.65 Million
Q4 2023 Jan 31, 2024	SELL	$31.71 - $38.95 $436,171 - $535,757	-13,755 Reduced 7.03%	181,927 $7.03 Million
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $3.02 Million - $3.99 Million	-80,940 Reduced 29.26%	195,682 $7.39 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $8.28 Million - $9.88 Million	207,122 Added 298.02%	276,622 $12.6 Million
Q1 2023 May 08, 2023	SELL	$37.58 - $52.57 $1.67 Million - $2.33 Million	-44,337 Reduced 38.95%	69,500 $2.82 Million
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $148,652 - $172,610	2,991 Added 2.7%	113,837 $5.8 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $221,633 - $274,882	-4,115 Reduced 3.58%	110,846 $5.97 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $40,915 - $51,280	641 Added 0.56%	114,961 $7.38 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $371,569 - $432,490	4,835 Added 4.42%	114,320 $8.86 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $194,702 - $227,653	-2,611 Reduced 2.33%	109,485 $9.4 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $2.68 Million - $3.04 Million	-36,308 Reduced 24.47%	112,096 $9.02 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $11.5 Million - $12.6 Million	-143,084 Reduced 49.09%	148,404 $11.9 Million
Q1 2021 May 13, 2021	SELL	$76.38 - $86.03 $3.22 Million - $3.63 Million	-42,189 Reduced 12.64%	291,488 $24.6 Million
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $8.95 Million - $9.77 Million	-118,682 Reduced 26.24%	333,677 $26.8 Million
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $10.8 Million - $12.5 Million	-137,403 Reduced 23.3%	452,359 $36.4 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $838,436 - $1 Million	10,659 Added 1.84%	589,762 $50.8 Million
Q1 2020 May 13, 2020	SELL	$71.57 - $93.3 $11.7 Million - $15.3 Million	-164,077 Reduced 22.08%	579,103 $47 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $20.2 Million - $23.3 Million	-263,600 Reduced 26.18%	743,180 $62.1 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $2.48 Million - $2.73 Million	-30,459 Reduced 2.94%	1,006,780 $88.1 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $11.2 Million - $12.6 Million	-152,937 Reduced 12.85%	1,037,239 $85 Million
Q1 2019 May 10, 2019	SELL	$64.48 - $81.31 $6.46 Million - $8.15 Million	-100,173 Reduced 7.76%	1,190,176 $96.8 Million
Q4 2018 Feb 13, 2019	SELL	$61.45 - $77.8 $9.68 Million - $12.3 Million	-157,465 Reduced 10.88%	1,290,349 $84.9 Million
Q3 2018 Nov 13, 2018	BUY	$70.71 - $77.75 $51.8 Million - $56.9 Million	731,914 Added 102.24%	1,447,814 $112 Million
Q2 2018 Aug 10, 2018	SELL	$63.43 - $75.41 $4.17 Million - $4.96 Million	-65,721 Reduced 8.41%	715,900 $52.9 Million
Q1 2018 May 09, 2018	SELL	$62.56 - $72.26 $8.07 Million - $9.32 Million	-128,982 Reduced 14.16%	781,621 $50.8 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $16.8 Million - $18 Million	272,867 Added 42.79%	910,603 $0
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $37.9 Million - $41.2 Million	637,736	637,736 $40 Million

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Baxter International Inc Transaction History